期刊文献+

Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl_4-induced hepatic fibrosis 被引量:42

Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl_4-induced hepatic fibrosis
下载PDF
导出
摘要 AIM: To explore the anti-fibrotic effect of Oxymatrine on CCl4-induced liver fibrosis in rats and its modulation on the TGFbeta-Smad signaling pathway. METHODS: One hundred healthy male SD rats were randomly divided into three groups: normal group (n = 20), treatment group of Oxymatrine (n = 40) and CCh-induced fibrosis group (n = 40). Experimental hepatic fibrosis was induced by subcutaneous injection of carbon tetrachloride (CCh soluted in liquid paraffin with the concentration of 300 g/L, the dosage of injection was 3 mL/kg, twice per week for 8 wk). The treated rats received Oxymatrine via celiac injection at a dosage of 10 mg/kg twice a week at the same time. The deposition of collagen was observed with H&E and Masson staining. The concentration of serum TGF-β1 was assayed with ELISA. The gene expression of Smads and CBP (CREB binding protein) was detected with in situ hybridization (ISH) and immunohistochemistry (IH), respectively. All the experimental figures were scanned and analyzed with special figure-analysis software. RESULTS: A significant reduction of collagen deposition and rearrangement of the parenchyma was noted in the liver tissue of Oxymatrine-treated rats. The semi- quantitative histological scores (2.43 ± 0.47 μm^2 vs 3.76 ±0.68, P 〈 0.05) and average area of collagen/in those rats were significantly decreased when compared with hepatic cirrhosis model rats (94.41 ± 37.26 μm^2 vs 290.86 ± 89.37 μm^2, P 〈 0.05). The gene expression of Smad 3 mRNA was considerably decreased in the treated animals. The A value of Smad 3 mRNA was lower in the treated rats than the model rats (0.034 ± 0.090 vs 0.167 ± 0.092, P 〈 0.05). Contrarily, the A value of Smad 7 mRNA was increased considerably in the treated animals (0.175 ± 0.065 vs 0.074 vs 0.012, P 〈 0.05). There was an obvious decrease in the expression of CBP mRNA in treated rats as illuminated by a reduction of its A value when compared with model rats (0.065±0.049 vs 0.235 ± 0.025, P 〈 0.001). CONCLUSION: Oxymatrine is effective in reducing the production and deposition of collagen in the liver tissue of experimental rats. Oxymatrine could promote the expression of Smad 7 and inhibit the expression of Smad 3 and CBP in CCh-induced hepatic fibrosis in SD rats, could modulate the fibrogenic signal transduction of TGFβ-Smad pathway. AIM: To explore the anti-fibrotic effect of Oxymatrine on CCl4-induced liver fibrosis in rats and its modulation on the TGFbeta-Smad signaling pathway. METHODS: One hundred healthy male SD rats were randomly divided into three groups: normal group (n = 20), treatment group of Oxymatrine (n = 40) and CCl4-induced fibrosis group (n = 40). Experimental hepatic fibrosis was induced by subcutaneous injection of carbon tetrachloride (CCl4 soluted in liquid paraffin with the concentration of 300 g/L, the dosage of injection was 3 mL/kg, twice per week for 8 wk). The treated rats received Oxymatrine via celiac injection at a dosage of 10 mg/kg twice a week at the same time. The deposition of collagen was observed with H&E and Masson staining. The concentration of serum TGF-β1 was assayed with ELISA. The gene expression of Smads and CBP (CREB binding protein) was detected with in situ hybridization (ISH) and immunohistochemistry (IH), respectively. All the experimental figures were scanned and analyzed with special figure-analysis software. RESULTS: A significant reduction of collagen deposition and rearrangement of the parenchyma was noted in the liver tissue of Oxymatrine-treated rats. The semi- quantitative histological scores (2.43 ± 0.47 μm2 vs 3.76 ± 0.68 μm2, P < 0.05) and average area of collagen in those rats were significantly decreased when compared with hepatic cirrhosis model rats (94.41 ± 37.26 μm2 vs 290.86 ± 89.37 μm2, P < 0.05). The gene expression of Smad 3 mRNA was considerably decreased in the treated animals. The A value of Smad 3 mRNA was lower in the treated rats than the model rats (0.034 ± 0.090 vs 0.167 ± 0.092, P < 0.05). Contrarily, the A value of Smad 7 mRNA was increased considerably in the treated animals (0.175 ± 0.065 vs 0.074 ± 0.012, P < 0.05). There was an obvious decrease in the expression of CBP mRNA in treated rats as illuminated by a reduction of its A value when compared with model rats (0.065 ± 0.049 vs 0.235 ± 0.025, P < 0.001). CONCLUSION: Oxymatrine is effective in reducing the production and deposition of collagen in the liver tissue of experimental rats. Oxymatrine could promote the expression of Smad 7 and inhibit the expression of Smad 3 and CBP in CCl4-induced hepatic fibrosis in SD rats, could modulate the fibrogenic signal transduction of TGFβ-Smad pathway.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第13期2100-2105,共6页 世界胃肠病学杂志(英文版)
基金 The Applied Basic Research of the Scientific Technological Department of Sichuan Province, No. 05JY0492
关键词 OXYMATRINE Hepatic Fibrosis TGF-Smad signaling 氧化苦参碱 肝纤维化 四氯化碳 TGF
  • 相关文献

参考文献2

二级参考文献68

  • 1[1]Friedman SL.Molecular regulation of hepatic fibrosis,an integrated cellular response to tissue injury.J Biol Chem 2000; 275:2247-2250
  • 2[2]Wu J,Zern MA.Hepatic stellate cells:a target for the treatment of liver fibrosis.J Gastroenterol 2000; 35:665-672
  • 3[3]Bataller R,Brenner DA.Liver fibrosis.J Clin Invest 2005; 115:209-218
  • 4[4]Nguyen TH,Ferry N.Liver gene therapy:advances and hurdles.Gene Ther 2004; 11 Suppl 1:S76-S84
  • 5[5]Canbay A,Friedman S,Gores GJ.Apoptosis:the nexus of liver injury and fibrosis.Hepatology 2004; 39:273-278
  • 6[6]Canbay A,Higuchi H,Bronk SF,Taniai M,Sebo TJ,Gores GJ.Fas enhances fibrogenesis in the bile duct ligated mouse:a link between apoptosis and fibrosis.Gastroenterology 2002; 123:1323-1330
  • 7[7]Torok N,Wu J,Zern MA,Halsted C,French S,Friedman SL,Zhan SS.Phagocytosis of apoptotic bodies by hepatic stellate cells occurs in vivo and is an important mechanism in liver fibrogenesis.Digestive Disease Week (DDW),May 14-19,2005,Chicago,IL (oral presentation,Abstract No.80).Gastroenterology 2005; 125:4(S2):A15
  • 8[8]Locksley RM,Killeen N,Lenardo MJ.The TNF and TNF receptor superfamilies:integrating mammalian biology.Cell 2001; 104:487-501
  • 9[9]Gores GJ,Kaufmann SH.Is TRAIL hepatotoxic? Hepatology 2001; 34:3-6
  • 10[10]Wallach D,Varfolomeev EE,Malinin NL,Goltsev YV,Kovalenko AV,Boldin MP.Tumor necrosis factor receptor and Fas signaling mechanisms.Annu Rev Immunol 1999; 17:331-367

共引文献61

同被引文献309

引证文献42

二级引证文献395

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部